These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 690847)

  • 1. Sex differences in plasma half-life of dextrorphan in rats administered dextromethorphan.
    Ramachander G; Bapatla KR; Emele JF
    J Pharm Sci; 1978 Sep; 67(9):1326-7. PubMed ID: 690847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of dextrorphan in plasma and evaluation of bioavailability of dextromethorphan hydrobromide in humans.
    Ramachander G; Williams FD; Emele JF
    J Pharm Sci; 1977 Jul; 66(7):1047-8. PubMed ID: 886444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of dextromethorphan and its major metabolite dextrorphan by gas chromatography].
    Kintz P; Mangin P; Lugnier A; Chaumont AJ
    Ann Biol Clin (Paris); 1989; 47(4):193-5. PubMed ID: 2751152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of dextrorphan and 3-hydroxymorphinan in human plasma based on a selective pre-column sample clean-up.
    Mascher H
    J Chromatogr; 1987 Sep; 420(1):217-22. PubMed ID: 3667825
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of salicylamide and acetaminophen on dextromethorphan hydrobromide metabolism: possible pharmacological implications.
    Ramachander G; Williams FD; Emele JF
    J Pharm Sci; 1978 Jun; 67(6):761-4. PubMed ID: 660449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.
    Schmid B; Bircher J; Preisig R; Küpfer A
    Clin Pharmacol Ther; 1985 Dec; 38(6):618-24. PubMed ID: 4064464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic differences in dextromethorphan metabolism.
    Vetticaden SJ; Cabana BE; Prasad VK; Purich ED; Jonkman JH; de Zeeuw R; Ball L; Leeson LJ; Braun RL
    Pharm Res; 1989 Jan; 6(1):13-9. PubMed ID: 2717511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.
    Silvasti M; Karttunen P; Tukiainen H; Kokkonen P; Hänninen U; Nykänen S
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):493-7. PubMed ID: 3679620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of dextromethorphan O-demethylation in man.
    Küpfer A; Schmid B; Pfaff G
    Xenobiotica; 1986 May; 16(5):421-33. PubMed ID: 3739367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextromethorphan and dextrorphan as calcium channel antagonists.
    Carpenter CL; Marks SS; Watson DL; Greenberg DA
    Brain Res; 1988 Jan; 439(1-2):372-5. PubMed ID: 2451974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.
    Tortella FC; Ferkany JW; Pontecorvo MJ
    Life Sci; 1988; 42(24):2509-14. PubMed ID: 3374269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.
    Mortimer O; Lindström B; Laurell H; Bergman U; Rane A
    Br J Clin Pharmacol; 1989 Feb; 27(2):223-7. PubMed ID: 2713216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antitussive effects of dextrorphan, dextromethorphan and phencyclidine.
    Lal J; Krutak-Krol H; Domino EF
    Arzneimittelforschung; 1986 Jul; 36(7):1075-8. PubMed ID: 3768075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan phenotypes in paediatric patients with autoimmune hepatitis.
    Jacqz-Aigrain E; Laurent J; Alvarez F
    Br J Clin Pharmacol; 1990 Jul; 30(1):153-4. PubMed ID: 2390427
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.
    Pechnick RN; Poland RE
    J Pharmacol Exp Ther; 2004 May; 309(2):515-22. PubMed ID: 14742749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture.
    Goldberg MP; Pham PC; Choi DW
    Neurosci Lett; 1987 Sep; 80(1):11-5. PubMed ID: 3658226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of dextromethorphan metabolizer phenotype in healthy volunteers.
    Hildebrand M; Seifert W; Reichenberger A
    Eur J Clin Pharmacol; 1989; 36(3):315-8. PubMed ID: 2744072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of dextromethorphan oxidation in a French population.
    Larrey D; Amouyal G; Tinel M; Letteron P; Berson A; Labbe G; Pessayre D
    Br J Clin Pharmacol; 1987 Nov; 24(5):676-9. PubMed ID: 3435696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.
    Larrey D; Babany G; Tinel M; Freneaux E; Amouyal G; Habersetzer F; Letteron P; Pessayre D
    Br J Clin Pharmacol; 1989 Sep; 28(3):297-304. PubMed ID: 2789923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T; Zeugin T; Küpfer A
    Biochem Pharmacol; 1988 Aug; 37(16):3155-60. PubMed ID: 3401246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.